APO Research
Talk to an analyst

APO RESEARCH · REPORT

Morquio Syndrome Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Research

Morquio Syndrome Treatment Industry Research Report 2026

19 December 2025127 pages

Choose your research edition.

Industry ResearchMorquio Syndrome Treatment Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Morquio Syndrome Treatment Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Morquio Syndrome Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Morquio Syndrome Treatment Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Morquio Syndrome Treatment Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Morquio Syndrome Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Morquio Syndrome Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Morquio Syndrome Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Morquio Syndrome Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Morquio Syndrome Treatment include Sanofi, Roche, Pfizer, Bayer, Shire, Sangamo Therapeutics, Lupin, JCR Pharmaceuticals and Green Cross, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Morquio Syndrome Treatment market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Morquio Syndrome Treatment.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Morquio Syndrome Treatment Market by Company

Sanofi

Roche

Pfizer

Bayer

Shire

Sangamo Therapeutics

Lupin

JCR Pharmaceuticals

Green Cross

Genzyme Corporation,

Daiichi Sankyo

Concert Pharmaceuticals

Cipla

Cambrex Corporation

BioMarin

Alexion Pharmaceuticals

Morquio Syndrome Treatment Segment by Type

Morquio A

Morquio B

Morquio Syndrome Treatment Segment by Application

Hospital

Clinic

Others

Morquio Syndrome Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Morquio Syndrome Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Morquio Syndrome Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Morquio Syndrome Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Morquio Syndrome Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Morquio Syndrome Treatment Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Morquio Syndrome Treatment Revenue Market Share by Type (2021-2026) Table 7. Global Morquio Syndrome Treatment Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Morquio Syndrome Treatment Revenue Market Share by Type (2027-2032) Table 9. Global Morquio Syndrome Treatment Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Morquio Syndrome Treatment Revenue Market Share by Application (2021-2026) Table 11. Global Morquio Syndrome Treatment Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Morquio Syndrome Treatment Revenue Market Share by Application (2027-2032) Table 13. Global Morquio Syndrome Treatment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Morquio Syndrome Treatment Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Morquio Syndrome Treatment Market Share by Region (2021-2026) Table 16. Global Morquio Syndrome Treatment Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Morquio Syndrome Treatment Market Share by Region (2027-2032) Table 18. Morquio Syndrome Treatment Industry Trends Table 19. Morquio Syndrome Treatment Industry Drivers Table 20. Morquio Syndrome Treatment Industry Opportunities and Challenges Table 21. Morquio Syndrome Treatment Market Restraints Table 22. Global Top Morquio Syndrome Treatment Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Morquio Syndrome Treatment Revenue Market Share by Players (2021-2026) Table 24. Global Morquio Syndrome Treatment Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Morquio Syndrome Treatment, Headquarters and Area Served Table 26. Global Morquio Syndrome Treatment Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Morquio Syndrome Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Morquio Syndrome Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Morquio Syndrome Treatment Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Morquio Syndrome Treatment Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Morquio Syndrome Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Morquio Syndrome Treatment Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Morquio Syndrome Treatment Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Morquio Syndrome Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Morquio Syndrome Treatment Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Morquio Syndrome Treatment Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Morquio Syndrome Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Morquio Syndrome Treatment Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Morquio Syndrome Treatment Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Morquio Syndrome Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2027-2032) & (US$ Million) Table 45. Sanofi Company Information Table 46. Sanofi Business Overview Table 47. Sanofi Revenue in Morquio Syndrome Treatment Business (2021-2026) & (US$ Million) Table 48. Sanofi Morquio Syndrome Treatment Product Portfolio Table 49. Sanofi Recent Developments Table 50. Roche Company Information Table 51. Roche Business Overview Table 52. Roche Revenue in Morquio Syndrome Treatment Business (2021-2026) & (US$ Million) Table 53. Roche Morquio Syndrome Treatment Product Portfolio Table 54. Roche Recent Developments Table 55. Pfizer Company Information Table 56. Pfizer Business Overview Table 57. Pfizer Revenue in Morquio Syndrome Treatment Business (2021-2026) & (US$ Million) Table 58. Pfizer Morquio Syndrome Treatment Product Portfolio Table 59. Pfizer Recent Developments Table 60. Bayer Company Information Table 61. Bayer Business Overview Table 62. Bayer Revenue in Morquio Syndrome Treatment Business (2021-2026) & (US$ Million) Table 63. Bayer Morquio Syndrome Treatment Product Portfolio Table 64. Bayer Recent Developments Table 65. Shire Company Information Table 66. Shire Business Overview Table 67. Shire Revenue in Morquio Syndrome Treatment Business (2021-2026) & (US$ Million) Table 68. Shire Morquio Syndrome Treatment Product Portfolio Table 69. Shire Recent Developments Table 70. Sangamo Therapeutics Company Information Table 71. Sangamo Therapeutics Business Overview Table 72. Sangamo Therapeutics Revenue in Morquio Syndrome Treatment Business (2021-2026) & (US$ Million) Table 73. Sangamo Therapeutics Morquio Syndrome Treatment Product Portfolio Table 74. Sangamo Therapeutics Recent Developments Table 75. Lupin Company Information Table 76. Lupin Business Overview Table 77. Lupin Revenue in Morquio Syndrome Treatment Business (2021-2026) & (US$ Million) Table 78. Lupin Morquio Syndrome Treatment Product Portfolio Table 79. Lupin Recent Developments Table 80. JCR Pharmaceuticals Company Information Table 81. JCR Pharmaceuticals Business Overview Table 82. JCR Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2021-2026) & (US$ Million) Table 83. JCR Pharmaceuticals Morquio Syndrome Treatment Product Portfolio Table 84. JCR Pharmaceuticals Recent Developments Table 85. Green Cross Company Information Table 86. Green Cross Business Overview Table 87. Green Cross Revenue in Morquio Syndrome Treatment Business (2021-2026) & (US$ Million) Table 88. Green Cross Morquio Syndrome Treatment Product Portfolio Table 89. Green Cross Recent Developments Table 90. Genzyme Corporation, Company Information Table 91. Genzyme Corporation, Business Overview Table 92. Genzyme Corporation, Revenue in Morquio Syndrome Treatment Business (2021-2026) & (US$ Million) Table 93. Genzyme Corporation, Morquio Syndrome Treatment Product Portfolio Table 94. Genzyme Corporation, Recent Developments Table 95. Daiichi Sankyo Company Information Table 96. Daiichi Sankyo Business Overview Table 97. Daiichi Sankyo Revenue in Morquio Syndrome Treatment Business (2021-2026) & (US$ Million) Table 98. Daiichi Sankyo Morquio Syndrome Treatment Product Portfolio Table 99. Daiichi Sankyo Recent Developments Table 100. Concert Pharmaceuticals Company Information Table 101. Concert Pharmaceuticals Business Overview Table 102. Concert Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2021-2026) & (US$ Million) Table 103. Concert Pharmaceuticals Morquio Syndrome Treatment Product Portfolio Table 104. Concert Pharmaceuticals Recent Developments Table 105. Cipla Company Information Table 106. Cipla Business Overview Table 107. Cipla Revenue in Morquio Syndrome Treatment Business (2021-2026) & (US$ Million) Table 108. Cipla Morquio Syndrome Treatment Product Portfolio Table 109. Cipla Recent Developments Table 110. Cambrex Corporation Company Information Table 111. Cambrex Corporation Business Overview Table 112. Cambrex Corporation Revenue in Morquio Syndrome Treatment Business (2021-2026) & (US$ Million) Table 113. Cambrex Corporation Morquio Syndrome Treatment Product Portfolio Table 114. Cambrex Corporation Recent Developments Table 115. BioMarin Company Information Table 116. BioMarin Business Overview Table 117. BioMarin Revenue in Morquio Syndrome Treatment Business (2021-2026) & (US$ Million) Table 118. BioMarin Morquio Syndrome Treatment Product Portfolio Table 119. BioMarin Recent Developments Table 120. Alexion Pharmaceuticals Company Information Table 121. Alexion Pharmaceuticals Business Overview Table 122. Alexion Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2021-2026) & (US$ Million) Table 123. Alexion Pharmaceuticals Morquio Syndrome Treatment Product Portfolio Table 124. Alexion Pharmaceuticals Recent Developments Table 125. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Morquio Syndrome Treatment Product Image Figure 5. Global Morquio Syndrome Treatment Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Morquio Syndrome Treatment Market Share by Type: 2025 VS 2032 Figure 7. Morquio A Product Figure 8. Morquio B Product Figure 9. Global Morquio Syndrome Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Morquio Syndrome Treatment Market Share by Application: 2025 VS 2032 Figure 11. Hospital Product Figure 12. Clinic Product Figure 13. Others Product Figure 14. Global Morquio Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 15. Global Morquio Syndrome Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Morquio Syndrome Treatment Market Share by Region: 2025 VS 2032 Figure 17. Global Morquio Syndrome Treatment Market Share by Players in 2025 Figure 18. Global Morquio Syndrome Treatment Manufacturers Established Date Figure 19. Global Top 5 and 10 Morquio Syndrome Treatment Players Market Share by Revenue in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. North America Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Morquio Syndrome Treatment Market Share by Country (2021-2032) Figure 23. United States Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Canada Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Mexico Morquio Syndrome Treatment Market Share by Country (2021-2032) Figure 26. Europe Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Europe Morquio Syndrome Treatment Market Share by Country (2021-2032) Figure 28. Germany Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. France Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. U.K. Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Italy Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Spain Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Russia Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Netherlands Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Nordic Countries Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Morquio Syndrome Treatment Market Share by Country (2021-2032) Figure 38. China Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Japan Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. South Korea Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. India Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Morquio Syndrome Treatment Market Share by Country (2021-2032) Figure 43. Australia Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. China Taiwan Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. Southeast Asia Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. South America Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Morquio Syndrome Treatment Market Share by Country (2021-2032) Figure 48. Brazil Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. Argentina Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Chile Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Colombia Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Peru Morquio Syndrome Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Sanofi Revenue Growth Rate in Morquio Syndrome Treatment Business (2021-2026) Figure 54. Roche Revenue Growth Rate in Morquio Syndrome Treatment Business (2021-2026) Figure 55. Pfizer Revenue Growth Rate in Morquio Syndrome Treatment Business (2021-2026) Figure 56. Bayer Revenue Growth Rate in Morquio Syndrome Treatment Business (2021-2026) Figure 57. Shire Revenue Growth Rate in Morquio Syndrome Treatment Business (2021-2026) Figure 58. Sangamo Therapeutics Revenue Growth Rate in Morquio Syndrome Treatment Business (2021-2026) Figure 59. Lupin Revenue Growth Rate in Morquio Syndrome Treatment Business (2021-2026) Figure 60. JCR Pharmaceuticals Revenue Growth Rate in Morquio Syndrome Treatment Business (2021-2026) Figure 61. Green Cross Revenue Growth Rate in Morquio Syndrome Treatment Business (2021-2026) Figure 62. Genzyme Corporation, Revenue Growth Rate in Morquio Syndrome Treatment Business (2021-2026) Figure 63. Daiichi Sankyo Revenue Growth Rate in Morquio Syndrome Treatment Business (2021-2026) Figure 64. Concert Pharmaceuticals Revenue Growth Rate in Morquio Syndrome Treatment Business (2021-2026) Figure 65. Cipla Revenue Growth Rate in Morquio Syndrome Treatment Business (2021-2026) Figure 66. Cambrex Corporation Revenue Growth Rate in Morquio Syndrome Treatment Business (2021-2026) Figure 67. BioMarin Revenue Growth Rate in Morquio Syndrome Treatment Business (2021-2026) Figure 68. Alexion Pharmaceuticals Revenue Growth Rate in Morquio Syndrome Treatment Business (2021-2026)

Scope & coverage.

Types
  • Morquio A
  • Morquio B
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Sanofi
  • Roche
  • Pfizer
  • Bayer
  • Shire
  • Sangamo Therapeutics
  • Lupin
  • JCR Pharmaceuticals
  • Green Cross
  • Genzyme Corporation,
  • Daiichi Sankyo
  • Concert Pharmaceuticals
  • Cipla
  • Cambrex Corporation
  • BioMarin
  • Alexion Pharmaceuticals

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Morquio Syndrome Treatment by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Morquio A
  5. 2.2.3 Morquio B
  6. 2.3 Morquio Syndrome Treatment by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  8. 2.3.2 Hospital
  9. 2.3.3 Clinic
  10. 2.3.4 Others
  11. 2.4 Assumptions and Limitations
3 Morquio Syndrome Treatment Breakdown Data by Type
  1. 3.1 Global Morquio Syndrome Treatment Historic Market Size by Type (2021-2026)
  2. 3.2 Global Morquio Syndrome Treatment Forecasted Market Size by Type (2027-2032)
4 Morquio Syndrome Treatment Breakdown Data by Application
  1. 4.1 Global Morquio Syndrome Treatment Historic Market Size by Application (2021-2026)
  2. 4.2 Global Morquio Syndrome Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Morquio Syndrome Treatment Market Perspective (2021-2032)
  2. 5.2 Global Morquio Syndrome Treatment Growth Trends by Region
  3. 5.2.1 Global Morquio Syndrome Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Morquio Syndrome Treatment Historic Market Size by Region (2021-2026)
  5. 5.2.3 Morquio Syndrome Treatment Forecasted Market Size by Region (2027-2032)
  6. 5.3 Morquio Syndrome Treatment Market Dynamics
  7. 5.3.1 Morquio Syndrome Treatment Industry Trends
  8. 5.3.2 Morquio Syndrome Treatment Market Drivers
  9. 5.3.3 Morquio Syndrome Treatment Market Challenges
  10. 5.3.4 Morquio Syndrome Treatment Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Morquio Syndrome Treatment Players by Revenue
  2. 6.1.1 Global Top Morquio Syndrome Treatment Players by Revenue (2021-2026)
  3. 6.1.2 Global Morquio Syndrome Treatment Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Morquio Syndrome Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Morquio Syndrome Treatment Head Office and Area Served
  6. 6.4 Global Morquio Syndrome Treatment Players, Product Type & Application
  7. 6.5 Global Morquio Syndrome Treatment Manufacturers Established Date
  8. 6.6 Global Morquio Syndrome Treatment Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Morquio Syndrome Treatment Market Size (2021-2032)
  2. 7.2 North America Morquio Syndrome Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Morquio Syndrome Treatment Market Size by Country (2021-2026)
  4. 7.4 North America Morquio Syndrome Treatment Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Morquio Syndrome Treatment Market Size (2021-2032)
  2. 8.2 Europe Morquio Syndrome Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Morquio Syndrome Treatment Market Size by Country (2021-2026)
  4. 8.4 Europe Morquio Syndrome Treatment Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Morquio Syndrome Treatment Market Size (2021-2032)
  2. 9.2 Asia-Pacific Morquio Syndrome Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Morquio Syndrome Treatment Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Morquio Syndrome Treatment Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Morquio Syndrome Treatment Market Size (2021-2032)
  2. 10.2 South America Morquio Syndrome Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Morquio Syndrome Treatment Market Size by Country (2021-2026)
  4. 10.4 South America Morquio Syndrome Treatment Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Morquio Syndrome Treatment Market Size (2021-2032)
  2. 11.2 Middle East & Africa Morquio Syndrome Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Sanofi
  2. 12.1.1 Sanofi Company Information
  3. 12.1.2 Sanofi Business Overview
  4. 12.1.3 Sanofi Revenue in Morquio Syndrome Treatment Business (2021-2026)
  5. 12.1.4 Sanofi Morquio Syndrome Treatment Product Portfolio
  6. 12.1.5 Sanofi Recent Developments
  7. 12.2 Roche
  8. 12.2.1 Roche Company Information
  9. 12.2.2 Roche Business Overview
  10. 12.2.3 Roche Revenue in Morquio Syndrome Treatment Business (2021-2026)
  11. 12.2.4 Roche Morquio Syndrome Treatment Product Portfolio
  12. 12.2.5 Roche Recent Developments
  13. 12.3 Pfizer
  14. 12.3.1 Pfizer Company Information
  15. 12.3.2 Pfizer Business Overview
  16. 12.3.3 Pfizer Revenue in Morquio Syndrome Treatment Business (2021-2026)
  17. 12.3.4 Pfizer Morquio Syndrome Treatment Product Portfolio
  18. 12.3.5 Pfizer Recent Developments
  19. 12.4 Bayer
  20. 12.4.1 Bayer Company Information
  21. 12.4.2 Bayer Business Overview
  22. 12.4.3 Bayer Revenue in Morquio Syndrome Treatment Business (2021-2026)
  23. 12.4.4 Bayer Morquio Syndrome Treatment Product Portfolio
  24. 12.4.5 Bayer Recent Developments
  25. 12.5 Shire
  26. 12.5.1 Shire Company Information
  27. 12.5.2 Shire Business Overview
  28. 12.5.3 Shire Revenue in Morquio Syndrome Treatment Business (2021-2026)
  29. 12.5.4 Shire Morquio Syndrome Treatment Product Portfolio
  30. 12.5.5 Shire Recent Developments
  31. 12.6 Sangamo Therapeutics
  32. 12.6.1 Sangamo Therapeutics Company Information
  33. 12.6.2 Sangamo Therapeutics Business Overview
  34. 12.6.3 Sangamo Therapeutics Revenue in Morquio Syndrome Treatment Business (2021-2026)
  35. 12.6.4 Sangamo Therapeutics Morquio Syndrome Treatment Product Portfolio
  36. 12.6.5 Sangamo Therapeutics Recent Developments
  37. 12.7 Lupin
  38. 12.7.1 Lupin Company Information
  39. 12.7.2 Lupin Business Overview
  40. 12.7.3 Lupin Revenue in Morquio Syndrome Treatment Business (2021-2026)
  41. 12.7.4 Lupin Morquio Syndrome Treatment Product Portfolio
  42. 12.7.5 Lupin Recent Developments
  43. 12.8 JCR Pharmaceuticals
  44. 12.8.1 JCR Pharmaceuticals Company Information
  45. 12.8.2 JCR Pharmaceuticals Business Overview
  46. 12.8.3 JCR Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2021-2026)
  47. 12.8.4 JCR Pharmaceuticals Morquio Syndrome Treatment Product Portfolio
  48. 12.8.5 JCR Pharmaceuticals Recent Developments
  49. 12.9 Green Cross
  50. 12.9.1 Green Cross Company Information
  51. 12.9.2 Green Cross Business Overview
  52. 12.9.3 Green Cross Revenue in Morquio Syndrome Treatment Business (2021-2026)
  53. 12.9.4 Green Cross Morquio Syndrome Treatment Product Portfolio
  54. 12.9.5 Green Cross Recent Developments
  55. 12.10 Genzyme Corporation,
  56. 12.10.1 Genzyme Corporation, Company Information
  57. 12.10.2 Genzyme Corporation, Business Overview
  58. 12.10.3 Genzyme Corporation, Revenue in Morquio Syndrome Treatment Business (2021-2026)
  59. 12.10.4 Genzyme Corporation, Morquio Syndrome Treatment Product Portfolio
  60. 12.10.5 Genzyme Corporation, Recent Developments
  61. 12.11 Daiichi Sankyo
  62. 12.11.1 Daiichi Sankyo Company Information
  63. 12.11.2 Daiichi Sankyo Business Overview
  64. 12.11.3 Daiichi Sankyo Revenue in Morquio Syndrome Treatment Business (2021-2026)
  65. 12.11.4 Daiichi Sankyo Morquio Syndrome Treatment Product Portfolio
  66. 12.11.5 Daiichi Sankyo Recent Developments
  67. 12.12 Concert Pharmaceuticals
  68. 12.12.1 Concert Pharmaceuticals Company Information
  69. 12.12.2 Concert Pharmaceuticals Business Overview
  70. 12.12.3 Concert Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2021-2026)
  71. 12.12.4 Concert Pharmaceuticals Morquio Syndrome Treatment Product Portfolio
  72. 12.12.5 Concert Pharmaceuticals Recent Developments
  73. 12.13 Cipla
  74. 12.13.1 Cipla Company Information
  75. 12.13.2 Cipla Business Overview
  76. 12.13.3 Cipla Revenue in Morquio Syndrome Treatment Business (2021-2026)
  77. 12.13.4 Cipla Morquio Syndrome Treatment Product Portfolio
  78. 12.13.5 Cipla Recent Developments
  79. 12.14 Cambrex Corporation
  80. 12.14.1 Cambrex Corporation Company Information
  81. 12.14.2 Cambrex Corporation Business Overview
  82. 12.14.3 Cambrex Corporation Revenue in Morquio Syndrome Treatment Business (2021-2026)
  83. 12.14.4 Cambrex Corporation Morquio Syndrome Treatment Product Portfolio
  84. 12.14.5 Cambrex Corporation Recent Developments
  85. 12.15 BioMarin
  86. 12.15.1 BioMarin Company Information
  87. 12.15.2 BioMarin Business Overview
  88. 12.15.3 BioMarin Revenue in Morquio Syndrome Treatment Business (2021-2026)
  89. 12.15.4 BioMarin Morquio Syndrome Treatment Product Portfolio
  90. 12.15.5 BioMarin Recent Developments
  91. 12.16 Alexion Pharmaceuticals
  92. 12.16.1 Alexion Pharmaceuticals Company Information
  93. 12.16.2 Alexion Pharmaceuticals Business Overview
  94. 12.16.3 Alexion Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2021-2026)
  95. 12.16.4 Alexion Pharmaceuticals Morquio Syndrome Treatment Product Portfolio
  96. 12.16.5 Alexion Pharmaceuticals Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst